Your browser doesn't support javascript.
loading
Improving attribution of adverse events in oncology clinical trials.
George, Goldy C; Barata, Pedro C; Campbell, Alicyn; Chen, Alice; Cortes, Jorge E; Hyman, David M; Jones, Lee; Karagiannis, Thomas; Klaar, Sigrid; Le-Rademacher, Jennifer G; LoRusso, Patricia; Mandrekar, Sumithra J; Merino, Diana M; Minasian, Lori M; Mitchell, Sandra A; Montez, Sandra; O'Connor, Daniel J; Pettit, Syril; Silk, Elaine; Sloan, Jeff A; Stewart, Mark; Takimoto, Chris H; Wong, Gilbert Y; Yap, Timothy A; Cleeland, Charles S; Hong, David S.
Afiliación
  • George GC; The University of Texas MD Anderson Cancer Center (MD Anderson), Houston, TX, United States.
  • Barata PC; Tulane University, New Orleans, LA, United States.
  • Campbell A; Genentech, South San Francisco CA.
  • Chen A; National Cancer Institute (NCI), Bethesda, MD, United States.
  • Cortes JE; MD Anderson, Houston, TX, United States.
  • Hyman DM; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Karagiannis T; Genentech, Chicago, IL, United States.
  • Klaar S; Swedish Medical Products Agency, Uppsala, Sweden.
  • Le-Rademacher JG; Mayo Clinic, Rochester, MN, United States.
  • LoRusso P; Yale University Cancer Center, New Haven, CT, United States.
  • Mandrekar SJ; Mayo Clinic, Rochester, MN, United States.
  • Merino DM; Friends of Cancer Research, Washington, DC, United States.
  • Minasian LM; NCI, Bethesda, MD, United States.
  • Mitchell SA; NCI, Rockville, MD, United States.
  • Montez S; MD Anderson, Houston, TX, United States.
  • O'Connor DJ; Medicines and Healthcare Products Regulatory Agency, London, United Kingdom.
  • Pettit S; Health and Environmental Sciences Institute, Washington DC, United States.
  • Sloan JA; Mayo Clinic, Rochester, MN, United States.
  • Stewart M; NCI, Bethesda, MD, United States.
  • Takimoto CH; Forty Seven, Inc., Menlo Park, CA, United States.
  • Wong GY; Pfizer, New York NY, United States.
  • Yap TA; MD Anderson, Houston, TX, United States.
  • Cleeland CS; MD Anderson, Houston, TX, United States. Electronic address: ccleeland@mdanderson.org.
  • Hong DS; MD Anderson, Houston, TX, United States. Electronic address: dshong@mdanderson.org.
Cancer Treat Rev ; 76: 33-40, 2019 Jun.
Article en En | MEDLINE | ID: mdl-31108240
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sistemas de Registro de Reacción Adversa a Medicamentos / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sistemas de Registro de Reacción Adversa a Medicamentos / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos